Deborah Y Moss (Debbie Moss)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Dna Damage Response

Endoplasmic Reticulum Stress

Oxidative Stress

Top Venues

Molecular cancer research : MCR

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Daryl Griffin, Robbie Carson, Deborah Y Moss, Tamas Sessler, Deborah P Lavin, Vijay K Tiwari, Shivaali Karelia, Richard D Kennedy, Kienan I Savage, Simon S McDade, Adam Carie, Jim Pankovich, Mark Bazett, Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation. Molecular cancer research : MCR (2024)
Daryl Griffin, Robbie Carson, Deborah Y Moss, Tamas Sessler, Deborah P Lavin, Vijay K Tiwari, Shivaali Karelia, Richard D Kennedy, Kienan I Savage, Simon S McDade, Adam Carie, Jim Pankovich, Mark Bazett, Sandra Van Schaeybroeck
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation. Molecular cancer research : MCR (2024)
Deborah Y Moss, Christopher McCann, Emma M Kerr
Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers. Science signaling 15 (756) (2022)